Tony J. C. Wang, M.D.
- New Patients Tel – (212) 305-5050
- Administrative Office Tel – (212) 305-7077
- Fax – (212) 305-5935
Outpatient Office Location
- The Irving Radiation Oncology Center
- Columbia University Medical Center
- 622 West 168th Street,
- New York, NY 10032
Tony Wang, M.D., is board certified in Radiation Oncology and an Associate Professor of Radiation Oncology (in Neurological Surgery) at New York-Presbyterian/Columbia University Medical Center. Dr. Wang cares for patients with all types of cancer, with extensive experience in malignant and benign brain tumors as well as cancers of the head and neck. His research interests are in Gamma Knife stereotactic radiosurgery and brain tumors. Dr. Wang received his B.A. and M.D. degrees from University of Missouri Kansas City Medical School, during which time he was also a Clinical Research Training Program Fellow at the National Institutes of Health, Bethesda, Maryland. He received internship training at Flushing Hospital Medical Center. Dr. Wang received his radiation oncology training at New York Presbyterian Hospital (Columbia campus), where he was Chief Resident from 2011-2012. He serves as a reviewer for various medical journals and is a member of several medical societies.
As a member of the Brain Tumor Center, Gamma Knife Center, and Pituitary Tumor Center, Dr. Wang is part of a multidisciplinary team that brings expertise from multiple specialties, including neurosurgery, neuro-oncology, neuroradiology, and neuro-endocrinology.
- Brain/Central Nervous System Tumors
- Gamma Knife radiosurgery
- Stereotactic radiosurgery
- Image Guided Radiation Therapy
- General Radiation Oncology
- Radiation Oncology
- Associate Professor of Radiation Oncology (in Neurological Surgery) at Columbia University Medical Center
- Associate Attending Radiation Oncologist at New York Presbyterian Hospital
- B.A./M.D. University of Missouri Kansas City Medical School
Internship and Residency
- Flushing Hospital Medical Center
- New York Presbyterian Hospital (Columbia campus)
- Clinical Research Training Program Fellow at the National Institutes of Health, Bethesda, Maryland
- American Society for Radiation Oncology
- American Society of Clinical Oncology
- Society for Neuro-Oncology
Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, Tian D, Vogelbaum MA, Wang TJ, Penas-Prado M, Youssef E, Blumenthal DT, Zhang P, Mehta MP, Barnholtz-Sloan JS. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: nrg oncology rtog 0525 and 0825. Neuro-Oncology. 2016.
Yanagihara TK, Saadatmand HJ, Wang TJ. Reevaluating stereotactic radiosurgery for glioblastoma: new potential for targeted dose-escalation. Journal of Neuro-Oncology. 2016; 130:397-411.
Yanagihara TK, Grinband J, Rowley J, Cauley KA, Lee A, Afghan M, Chu A, Wang TJ. A simple automated method for detecting recurrence in high-grade glioma. American Journal of Neuroradiology. 2016; 37:2019-2025
Garrett MD, Wu CC, Yanagihara TK, Jani A, Wang TJ. Radiation therapy for the management of brain metastases. American Journal of Clinical Oncology. 2016; 39:416-422.
Jani A, Wang TJ, Sisti MB. In reply: how long should we wait for delivery treatment after surgery? An enigma yet to be solved. Neurosurgery. 2016; 79:E166-167.
Wang TJ, Wu CC, Jani A, Estrada J, Ung T, Chow DS, Soun JE, Saad S, Qureshi YH, Gartrell R, Saadatmand HJ, Saraf A, Garrett MD, Grubb C, Isaacson SR, Cheng SK, Sisti MB, Bruce JN, Sheth SA, Lassman AB, Iwamoto FM, McKhann GM 2nd. Hypofractionated radiation therapy versus standard fractionated radiation therapy with concurrent temozolomide in elderly patients with newly diagnosed glioblastoma. Practical Radiation Oncology. 2016; 6:306-314
Saadatmand HJ, Wu CC, Wang TJ*. Interdisciplinary management of acoustic neuromas. Applied Radiation Oncology. 2016; 5(1):5-16.
Wu CC, Wang TJ, Jani A, Estrada J, Ung T, Chow DS, Soun J, Saad S, Qureshi YH, Gartrell R, Saadatmand HJ, Saraf A, Garrett MD, Grubb C, Isaacson SR, Cheng SK, Sisti MB, Bruce JN, Sheth SA, Lassman AB, McKhann GM. A modern radiotherapy series of survival in hispanic glioblastoma patients. World Neurosurgery. 2016; 88:260-269.
Grubb CS, Jani A, Wu CC, Saad S, Qureshi YH, Nanda T, Yaeh A, Rozenblat T, Sisti MB, Bruce JN, McKhann GM, Sheth SA, Lesser JA, Cheng SK, Isaacson SR, Lassman AB, Connolly EP, Wang TJ*. Breast cancer subtype as a predictor for outcomes and control in the setting of brain metastases treated with stereotactic radiosurgery. Journal of Neuro-Oncology. 2016; 127:103-110.
Wang TJ, Jani A, Estrada JP, Ung TH, Chow DS, Soun JE, Saad S, Qureshi YH, Gartrell R, Isaacson SR, Cheng SK, McKhann GM, Bruce JN, Lassman AB, Cheng SK, Sisti MB. Timing of adjuvant radiation therapy in glioblastoma patients: a single-institution experience with more than 400 patients. Neurosurgery. 2016; 78:676-682.
Wu CC, Horowitz DP, Deutsch I, Rahmati R, Schecter JM, Saqi A, Wang TJ*. De-escalation of radiation dose for hpv-positive oropharyngeal head and neck squamous cell carcinoma: a case report and preclinical and clinical literature review. Oncology Letters. 2016; 11:141-149.
Wang TJ, Wu CC, Chai Y, Lam RK, Hamada N, Kakinuma S, Uchihori Y, Yu PK, Hei TK. Induction of non-targeted stress response in mammary tissues by heavy ions. PLoS One. 2015; 10(8):e0136307.
Yaeh A, Nanda T, Rozenblat T, Jani A, Qureshi Y, Saad S, Lesser J, Lassman AB, Isaacson SR, Sisti MB, Bruce JN, McKhann GM, Wang TJ*. Control of brain metastases from radioresistant tumors treated by stereotactic radiosurgery. Journal of Neuro-Oncology. 2015; 124:507-514.
Wang TJ, Saad S, Qureshi YH, Jani A, Nanda T, Yaeh AM, Rozenblat T, Sisti MB, Bruce JN, McKhann GM, Lassman AB, Cheng SK, Isaacson SR. Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastasis treated with radiation?. Neuro-Oncology. 2015; 17:1022-1028.
Jani A, Rozenblat T, Yaeh AM, Nanda T, Saad S, Qureshi YH, Feng W, Sisti MB, Bruce J, McKhann GM, Lesser J, Lassman AB, Isaacson SR, Wang TJ*. The energy index does not affect local control of brain metastases treated by gamma knife stereotactic radiosurgery. Neurosurgery. 2015; 77:119-125.
Wang TJ, Riaz N, Lee NY. Dorsal vagal complex of the brainstem: conformal avoidance to reduce nausea In Regard to Monroe et al. Practical Radiation Oncology. 2015; 5:e57.
Wang TJ, Saad S, Qureshi YH, Isaacson SR, Sisti MB, Bruce JN, McKhann GM, Lesser J, Cheng SK, Chao KS, Lassman AB. Outcomes of gamma knife radiosurgery, bi-modality & trimodality treatment regimens for patients with one or multiple brain metastases: the Columbia University Medical Center experience. Journal of Neuro-Oncology. 2015; 122:399-408.
Saad S, Wang TJ*. Neurocognitive deficits after radiation therapy for brain malignancies. American Journal of Clinical Oncology. 2015; 38:634-640.
Yanagihara T, Wang TJ*. Diffusion weighted imaging of the brain for glioblastoma, implications for radiation- and neurooncology. Applied Radiation Oncology. 2014; 3(4):5-13.
Saad S, Wang TJ*. Nasopharyngeal carcinoma: current treatment options and future directions. Journal of Nasopharyngeal Carcinoma. 2014; 1:e16.
Horowitz DP*, Wang TJ*, Wuu CS, Feng W, Drassinower D, Lasala A, Pieniazek R, Cheng S, Connolly EP, Lassman AB. Fetal radiation monitoring and dose minimization during intensity modulated radiation therapy for glioblastoma in pregnancy. Journal of Neuro-Oncology. 2014; 120:405-409.
Riaz N, Hong JC, Sherman EJ, Morris L, Fury M, Ganly I, Wang TJ, Shi W, Wolden SL, Jackson A, Wong RJ, Zhang Z, Rao SD, Lee NY. A nomogram to predict loco-regional control after re-irradiation for head and neck cancer. Radiotherapy and Oncology. 2014; 11:382-387.
Wang TJ, Riaz N, Zhang C, Youssef B, Hong JC, Born H, Wolden S, Rao S, Lee NY. Patterns of failure (pof) after salvage re-irradiation for recurrent head and neck: implications for field design and consolidation therapy. Journal of Radiation Oncology. 2014; 3:139-145.
Wang TJ, Zhang C, Wei Y, Kessel J, Chao KS, Hei TK, Deutsch I. Comparison of effect of rectal volume delineation methods on dose constraint endpoints in the treatment of prostate cancer with intensity-modulated radiation therapy. Journal of Radiation Oncology. 2013; 2:303-308.
Wang TJ, Fontenla S, McCann P, Young RJ, McNamara S, Rao S, Mechalakos JG, Lee NY. Correlation of planned dose to area postrema and dorsal vagal complex with clinical symptoms of nausea and vomiting in a series of oropharyngeal cancer (opc) patients treated with radiation alone using IMRT. Journal of Radiation Oncology. 2013; 2:407-412.
Wang TJ, Menda Y, Cheng SK, Wu CC, Lee NY. New Tracers PET in Head and Neck Squamous Cell Carcinoma. PET Clinics. 2012; 7:431-441.
Wang TJ, Riaz N, Cheng SK, Lu JJ, Lee NY. Intensity-Modulated Radiation Therapy for Nasopharyngeal Carcinoma: A Review. Journal of Radiation Oncology. 2012; 1:129-146.
Jia Y, Wang TJ, Allendorf J, Saif MW. Management of borderline resectable pancreatic adenocarcinoma. Journal of the Pancreas. 2012; 13:147-150.
Wang TJ, Lee NY, Young RJ. An unusual cause of isolated vomiting. Neurology. 2012; 78:72-73.
Wang TJ, Brisman R, Lu ZF, Li X, Isaacson SR, Shah JN, Yoshida EJ, Liu T. Image registration strategy of T(1)-weighted and FIESTA MRI sequences in trigeminal neuralgia gamma knife radiosurgery. Stereotactic and Functional Neurosurgery. 2010; 88:239-245.
Liu T, Zhou J, Yoshida EJ, Woodhouse SA, Schiff PB, Wang TJ, Lu ZF, Pile-Spellman E, Zhang P, Kutcher GJ. Quantitative ultrasonic imaging of radiation-induced late tissue toxicity: pilot study in breast-cancer radiotherapy. International Journal of Radiation Oncology, Biology and Physics. 2010; 78:811-820.
Zhao W, Chuang EY, Mishra M, Awwad R, Bisht K, Sun L, Nguyen P, Pennington JD, Wang TJ, Bradbury CM, Huang L, Chen Z, Bar-Sela G, Robbins ME, Gius D. Distinct effects of ionizing radiation on in vivo murine kidney and brain normal tissue gene expression. Clinical Cancer Research. 2006; 12:3823-3830.
Pennington JD, Wang TJ, Nguyen P, Sun L, Bisht K, Smart D, Gius D. Redox sensitive signaling factors as a novel molecular targets for cancer therapy. Drug Resistance Updates. 2005; 8:322-330.